Complete disappearance of red thrombi in a drug-eluting stent despite discontinuation of antiplatelet therapy: Angioscopic confirmation

Wenaweser, 2008, Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice, J Am Coll Cardiol, 52, 1134, 10.1016/j.jacc.2008.07.006 McFadden, 2004, Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy, Lancet, 364, 1519, 10.1016/S0140-6736(04)17275-9 Takano, 2007, Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy, Heart, 93, 1533, 10.1136/hrt.2007.131714 Fujii, 2011, Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation, Heart, 97, 977, 10.1136/hrt.2010.204594 Kotani, 2006, Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings, J Am Coll Cardiol, 47, 2108, 10.1016/j.jacc.2005.11.092 Sera, 2009, Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy, JACC Cardiovasc Interv, 10, 989, 10.1016/j.jcin.2009.07.006 Yamamoto, 2009, Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy, Am Heart J, 158, 99, 10.1016/j.ahj.2009.04.016 Nishino, 2010, Vulnerable disease may induce neointimal coverage after sirolimus-eluting stent implantation, Am Heart J, 160, 564, 10.1016/j.ahj.2010.06.043 Tanaka, 2010, Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation, J Am Coll Cardiol Interv, 3, 1074, 10.1016/j.jcin.2010.08.006